Tissue penetration and half-life of cefonicid.
The pharmacokinetics of cefonicid in the serum and tissues of patients undergoing open heart surgery, vaginal hysterectomy, and hip replacement was studied and compared with that of cefazolin and cefoxitin. Cefonicid achieved serum and tissue concentrations that were higher and more prolonged than those of cefazolin and cefoxitin. For cefonicid parallelism was observed between the serum and tissue concentration-time curves. Correlations of these properties to clinical efficacy were not attempted.
D000328:Adult; D000368:Aged; D006348:Cardiac Surgical Procedures; D002435:Cefamandole / Q000031:analogs & derivatives* / Q000378:metabolism; D002437:Cefazolin / Q000378:metabolism; D015790:Cefonicid; D002440:Cefoxitin / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006207:Half-Life; D006622:Hip Prosthesis; D006801:Humans; D007044:Hysterectomy; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011292:Premedication; D013997:Time Factors; D014018:Tissue Distribution
D002435:Cefamandole; D015790:Cefonicid; D002440:Cefoxitin; D002437:Cefazolin